Company intelligence / Profile preview

Nurasa

Ownership: Private
Development stage: Commercial

Overview

Nurasa provides infrastructure and expertise to accelerate the development and commercialization of sustainable foods—especially alternative proteins—through its FTIC facility. It supports startups and corporates with R&D labs for precision fermentation and plant-based protein production. The company does not have clinical results as it does not develop therapeutics or drugs.

Modalities: Precision fermentationPlant protein extrusionFood processing technologies
Industry: Food & Nutrition

Partnerships

ScaleUp Bio joint venture with ADM/A*STAR for precision fermentation scale-upCremer Sustainable Foods joint venture with German agrifood giant Cremer AGCollaborations with A*STAR research institutePartnership with Saskatchewan Food Centre for global market access

Beyond the preview

Go deeper on Nurasa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nurasa.

Explore the full profile